Close Search
 
MEDIA, JOBS & RESOURCES for the COMMON GOOD

Australasian Leukaemia & Lymphoma Group (ALLG)

Contact

Name: Kate Halford

Position: Partnerships & Fundraising Manager

Email: kate.halford@allg.org.au

Website: https://www.allg.org.au

Address

35 Elizabeth St

Richmond VIC 3121

Share us on social media

Follow

Our Mission / Objective

ALLG’s mission is to design, develop and deliver clinical trials that create better treatments and better lives for patients living with blood cancers like leukaemia, lymphoma and myeloma. 

Our Services

ALLG is Australasia’s only collaborative clinical trial group for blood cancers. Our clinician Members lead the way for Australian blood cancer patients to access the newest and promising treatments from around the world, right here in Australia.

Medical research and clinical trials are critical to test and advance new treatments to help blood cancer once and for all. Simply, clinical trials are the basis for every new cancer treatment available to patients.

The ALLG provides the infrastructure and governance necessary for Australian and New Zealand clinicians and scientists to work together to conduct multi-disciplinary clinical research into blood cancers.

Currently, more than 900 clinicians, scientists and support staff across Australia and New Zealand contribute to ALLG research.

By conducting multi-site, collaborative clinical trials, ALLG researchers play a pivotal role in influencing blood cancer treatment practice worldwide and improving treatments and outcomes for people with blood cancers.

Our Beneficiaries

ALLG’s clinical research benefits patients suffering from blood cancers like leukaemia, lymphoma, myeloma and others, across Australia, New Zealand and internationally. 

Blood cancers can affect anyone, anywhere, at any time. Each day, 50 Australians are diagnosed with a blood cancer.

ALLG’s critical clinical research is focused on improving the treatments and quality of life for blood cancer patients. 

Projects in Progress

Clinical Trials

Please click here to see a list of our current clinical trials.

National Blood Cancer Registry (NBCR)

The NBCR was designed to give real world data linking demographic, cancer cytogenetic, clinical and treatment outcome information and offers a longitudinal clinical pathway for each participating patient.

The NBCR fills current gaps in knowledge and research capacity to form a collaborative model framework. The framework is equipped to develop evidenced-based policy and improve the diagnosis, treatment and outcomes for patients with Acute Myeloid Leukaemia (AML), Acute Lymphoblastic Leukaemia (ALL) and Uncommon Lymphomas.

By systematically collecting patient information, the NBCR provides serial longitudinal data for blood cancer patients throughout Australia and New Zealand.

Biobank

A biobank is a central repository of human tissue samples from blood, bone marrow or other tissue. The biobank receives and stores specimens from patients with haematological malignancies participating in ALLG investigator initiated clinical trials and the ALLG National Blood Cancer Registry (NBCR).

The aim of the biobank is to facilitate the conduct of research thereby augmenting the benefits of our clinical research into haematological malignancies. The function of the biobank will be to provide samples from patients with these diseases for use in ethically approved research projects thereby facilitating a wide range of research activities. The ultimate goal of facilitating such research is to improve our understanding of the processes leading to the development of haematological malignancies, factors which govern the variable response to current treatments and ultimately the development of more effective therapies for patients suffering from haematological malignancies.

Our People

CEO

Delaine Smith, CEO

Leadership Team

Kelly Hetherton, Business Manager

Kate Halford, Partnerships & Fundraising Manager

Tanya Carter, Marketing & Communications Manager

Juliet Brereton, Events & Communications Coordinator

Tracey Gerber, Business Development Manager 

Names of Board Members

Peter T Kempen (Chairman)

A/Prof Peter Mollee

Geraldine Gray

Malcolm McComas

Tina Rankovic 

Prof Andrew Roberts

Prof Philip Rowlings

Prof Peter Browett

Lisa Keenan

Registration Information

ABN

96 066 593 100

Tax Deductible

Yes

How to help us

Wills and Bequests

A world without blood cancer could be the long-lasting legacy you leave behind to your loved ones.

When you leave a bequest to the ALLG, you are providing some of Australia’s leading researchers with the power to end blood cancer sooner.

We are always extremely grateful to those who leave their last gift to the advancement of blood cancer research. Whether the gift is cash, a whole or percentage of an estate, antique jewellery, paintings, real estate or shares, the ALLG is honoured to have you as someone leaving such a long-lasting impact.

General Donations

Research breakthroughs of the near future need perseverance and funding; we are so grateful to the generosity of donors in our community, whose contributions — both large and small — have enabled us to continue our work.

The gift you make today will make a difference in the life of someone who has blood cancer. Thank you for supporting breakthrough cancer research with your kind donation.

Other support

You can also support the ALLG by donating through your workplace, fundraising for the ALLG or purchasing an Entertainment Book with profits going directly to fund clinical trials. 

To find out more, visit our website

Work with us

Please visit our website for any new career opportunities. 

Volunteer with us

Our Annual Reports

Our Mission / Objective

ALLG’s mission is to design, develop and deliver clinical trials that create better treatments and better lives for patients living with blood cancers like leukaemia, lymphoma and myeloma. 

Our Services

ALLG is Australasia’s only collaborative clinical trial group for blood cancers. Our clinician Members lead the way for Australian blood cancer patients to access the newest and promising treatments from around the world, right here in Australia.

Medical research and clinical trials are critical to test and advance new treatments to help blood cancer once and for all. Simply, clinical trials are the basis for every new cancer treatment available to patients.

The ALLG provides the infrastructure and governance necessary for Australian and New Zealand clinicians and scientists to work together to conduct multi-disciplinary clinical research into blood cancers.

Currently, more than 900 clinicians, scientists and support staff across Australia and New Zealand contribute to ALLG research.

By conducting multi-site, collaborative clinical trials, ALLG researchers play a pivotal role in influencing blood cancer treatment practice worldwide and improving treatments and outcomes for people with blood cancers.

Our Beneficiaries

ALLG’s clinical research benefits patients suffering from blood cancers like leukaemia, lymphoma, myeloma and others, across Australia, New Zealand and internationally. 

Blood cancers can affect anyone, anywhere, at any time. Each day, 50 Australians are diagnosed with a blood cancer.

ALLG’s critical clinical research is focused on improving the treatments and quality of life for blood cancer patients. 

Projects in Progress

Clinical Trials

Please click here to see a list of our current clinical trials.

National Blood Cancer Registry (NBCR)

The NBCR was designed to give real world data linking demographic, cancer cytogenetic, clinical and treatment outcome information and offers a longitudinal clinical pathway for each participating patient.

The NBCR fills current gaps in knowledge and research capacity to form a collaborative model framework. The framework is equipped to develop evidenced-based policy and improve the diagnosis, treatment and outcomes for patients with Acute Myeloid Leukaemia (AML), Acute Lymphoblastic Leukaemia (ALL) and Uncommon Lymphomas.

By systematically collecting patient information, the NBCR provides serial longitudinal data for blood cancer patients throughout Australia and New Zealand.

Biobank

A biobank is a central repository of human tissue samples from blood, bone marrow or other tissue. The biobank receives and stores specimens from patients with haematological malignancies participating in ALLG investigator initiated clinical trials and the ALLG National Blood Cancer Registry (NBCR).

The aim of the biobank is to facilitate the conduct of research thereby augmenting the benefits of our clinical research into haematological malignancies. The function of the biobank will be to provide samples from patients with these diseases for use in ethically approved research projects thereby facilitating a wide range of research activities. The ultimate goal of facilitating such research is to improve our understanding of the processes leading to the development of haematological malignancies, factors which govern the variable response to current treatments and ultimately the development of more effective therapies for patients suffering from haematological malignancies.

Our People

CEO

Delaine Smith, CEO

Leadership Team

Kelly Hetherton, Business Manager

Kate Halford, Partnerships & Fundraising Manager

Tanya Carter, Marketing & Communications Manager

Juliet Brereton, Events & Communications Coordinator

Tracey Gerber, Business Development Manager 

Names of Board Members

Peter T Kempen (Chairman)

A/Prof Peter Mollee

Geraldine Gray

Malcolm McComas

Tina Rankovic 

Prof Andrew Roberts

Prof Philip Rowlings

Prof Peter Browett

Lisa Keenan

Registration Information

ABN

96 066 593 100

Tax Deductible

Yes

How to Help us

Wills and Bequests

A world without blood cancer could be the long-lasting legacy you leave behind to your loved ones.

When you leave a bequest to the ALLG, you are providing some of Australia’s leading researchers with the power to end blood cancer sooner.

We are always extremely grateful to those who leave their last gift to the advancement of blood cancer research. Whether the gift is cash, a whole or percentage of an estate, antique jewellery, paintings, real estate or shares, the ALLG is honoured to have you as someone leaving such a long-lasting impact.

General Donations

Research breakthroughs of the near future need perseverance and funding; we are so grateful to the generosity of donors in our community, whose contributions — both large and small — have enabled us to continue our work.

The gift you make today will make a difference in the life of someone who has blood cancer. Thank you for supporting breakthrough cancer research with your kind donation.

Other support

You can also support the ALLG by donating through your workplace, fundraising for the ALLG or purchasing an Entertainment Book with profits going directly to fund clinical trials. 

To find out more, visit our website

Work with us

Please visit our website for any new career opportunities. 

Volunteer with us

Our Annual Reports

PRINT

Featured not for profits


One of SA's largest disability service providers we work wit...

Cara Inc


We are the only independent medical research institute in Au...

Children’s Cancer Institute


You might be interested in


Bridging the gaps Australia’s mental health system is frag...

Towards Integrated Mental Health Services


pba inverse logo
Subscribe Twitter Facebook
×